Biodesix Faces Delisting Concerns

Ticker: BDSX · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1439725

Biodesix Inc 8-K Filing Summary
FieldDetail
CompanyBiodesix Inc (BDSX)
Form Type8-K
Filed DateMar 28, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory-filing

TL;DR

Biodesix is on the verge of being delisted, major red flag!

AI Summary

Biodesix, Inc. filed an 8-K on March 28, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective March 24, 2025. The company is incorporated in Delaware and headquartered in Louisville, Colorado.

Why It Matters

This filing indicates potential issues with Biodesix's continued listing on an exchange, which could impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event for a publicly traded company.

Key Players & Entities

  • Biodesix, Inc. (company) — Registrant
  • March 24, 2025 (date) — Earliest event date
  • March 28, 2025 (date) — Filing date
  • Delaware (jurisdiction) — State of incorporation
  • Louisville, Colorado (location) — Principal executive office
  • 80027 (zip_code) — Principal executive office zip code
  • (303) 417-0500 (phone_number) — Registrant's telephone number

FAQ

What specific listing rule or standard did Biodesix, Inc. fail to satisfy?

The filing does not specify the exact rule or standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

When did the event triggering this 8-K filing occur?

The earliest event reported in this filing occurred on March 24, 2025.

What is the filing date of this 8-K report?

This 8-K report was filed as of March 28, 2025.

Where is Biodesix, Inc. headquartered?

Biodesix, Inc.'s principal executive office is located at 919 West Dillon Rd, Louisville, Colorado, 80027.

What is the Commission File Number for Biodesix, Inc.?

The Commission File Number for Biodesix, Inc. is 001-39659.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding BIODESIX INC (BDSX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.